ÂÜÀòÂÒÂ×

Carol Gaddum has a diverse work experience spanning various roles and industries. Carol began their career as a Trainee at Fresenius SE in 2005 and worked there until 2008. Carol then joined Deutsche Bank as an Analyst in 2010 for a brief period of six months. In 2011, Carol joined ZS as a Manager and held that position for eight years until 2019. During this time, they gained expertise in analytics and management. In 2019, they joined Portola Pharmaceuticals as a Senior Director, focusing on forecasting and analytics. After two years, they moved on to FibroGen, Inc. in 2021, where they initially served as the Senior Director of Analytics, Forecasting & Commercial Operations and later took on the role of Executive Director of Forecasting, Analytics & New Product Planning in March 2022. Carol has proven experience in forecasting, analytics, commercial operations, and new product planning in the pharmaceutical industry.

Carol Gaddum pursued their education in a chronological manner. Starting in 2005, they attended accadis Hochschule and completed their Bachelor's degree in International Business Administration by 2008. Building on this foundation, from 2008 to 2010, they undertook further studies at The London School of Economics and Political Science (LSE), obtaining a Master of Science (MSc) degree in Management.